Dan G. Duda, DMD, PhD
Dan G. Duda, DMD, PhD
Professor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School
Verified email at - Homepage
Cited by
Cited by
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ...
Nature medicine 10 (2), 145-147, 2004
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ...
Cancer cell 11 (1), 83-95, 2007
Normalization of the vasculature for treatment of cancer and other diseases
S Goel, DG Duda, L Xu, LL Munn, Y Boucher, D Fukumura, RK Jain
Physiological reviews 91 (3), 1071-1121, 2011
Angiogenesis in brain tumours
RK Jain, E Di Tomaso, DG Duda, JS Loeffler, AG Sorensen, TT Batchelor
Nature Reviews Neuroscience 8 (8), 610-622, 2007
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
RK Jain, DG Duda, JW Clark, JS Loeffler
Nature clinical practice Oncology 3 (1), 24-40, 2006
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
D Fukumura, J Kloepper, Z Amoozgar, DG Duda, RK Jain
Nature reviews Clinical oncology 15 (5), 325-340, 2018
Engineering vascularized tissue
RK Jain, P Au, J Tam, DG Duda, D Fukumura
Nature biotechnology 23 (7), 821-823, 2005
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Y Huang, J Yuan, E Righi, WS Kamoun, M Ancukiewicz, J Nezivar, ...
Proceedings of the National Academy of Sciences 109 (43), 17561-17566, 2012
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Nunez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...
Nature 592 (7854), 450-456, 2021
Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma
A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ...
Cancer discovery 7 (10), 1116-1135, 2017
Biomarkers of response and resistance to antiangiogenic therapy
RK Jain, DG Duda, CG Willett, DV Sahani, AX Zhu, JS Loeffler, ...
Nature reviews Clinical oncology 6 (6), 327-338, 2009
Vascular normalization as an emerging strategy to enhance cancer immunotherapy
Y Huang, S Goel, DG Duda, D Fukumura, RK Jain
Cancer research 73 (10), 2943-2948, 2013
Malignant cells facilitate lung metastasis by bringing their own soil
DG Duda, AMMJ Duyverman, M Kohno, M Snuderl, EJA Steller, ...
Proceedings of the National Academy of Sciences 107 (50), 21677-21682, 2010
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
RR Ramjiawan, AW Griffioen, DG Duda
Angiogenesis 20, 185-204, 2017
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study
CG Willett, DG Duda, E Di Tomaso, Y Boucher, M Ancukiewicz, ...
Journal of Clinical Oncology 27 (18), 3020, 2009
HCC and angiogenesis: possible targets and future directions
AX Zhu, DG Duda, DV Sahani, RK Jain
Nature reviews Clinical oncology 8 (5), 292-301, 2011
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
M Stroh, JP Zimmer, DG Duda, TS Levchenko, KS Cohen, EB Brown, ...
Nature medicine 11 (6), 678-682, 2005
Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
TT Batchelor, DG Duda, E di Tomaso, M Ancukiewicz, SR Plotkin, ...
Journal of Clinical Oncology 28 (17), 2817, 2010
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
AX Zhu, DV Sahani, DG Duda, E di Tomaso, M Ancukiewicz, OA Catalano, ...
Journal of clinical oncology 27 (18), 3027, 2009
Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre‐clinical models
DAI Fukumura, DG Duda, LL Munn, RK Jain
Microcirculation 17 (3), 206-225, 2010
The system can't perform the operation now. Try again later.
Articles 1–20